[Cutaneous reactivity to 48/80 in subjects treated with lysozyme].
D000279:Administration, Cutaneous; D000891:Anti-Infective Agents, Local; D003879:Dermatologic Agents; D009113:Muramidase / Q000494:pharmacology*; D012867:Skin / Q000494:pharmacology*; D013501:Surface-Active Agents / Q000494:pharmacology*
D000891:Anti-Infective Agents, Local; D003879:Dermatologic Agents; D013501:Surface-Active Agents; D009113:Muramidase
LYSOZYME/pharmacology; SKIN/pharmacology; SURFACE-ACTIVE AGENTS/pharmacology